Joel T Rämö1,2, Sanna M Kaye1, Sakari Jukarainen1, Leonie H Bogl3, Antti Hakkarainen4, Jesper Lundbom5,6, Nina Lundbom4, Aila Rissanen1,7, Jaakko Kaprio2,3,8, Niina Matikainen1,9, Kirsi H Pietiläinen1,2,9. 1. Obesity Research Unit, Research Programs Unit, Diabetes and Obesity, FI-00029, Helsinki, Finland. 2. Institute for Molecular Medicine Finland, FI-00014, Helsinki, Finland. 3. Department of Public Health, University of Helsinki, FI-00014, Helsinki, Finland. 4. Department of Radiology, HUS Medical Imaging Center, Helsinki University Hospital, University of Helsinki, FI-00029, Helsinki, Finland. 5. Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, 40225, Düsseldorf, Germany. 6. German Center for Diabetes Research, Partner Düsseldorf, 40225, Düsseldorf, Germany. 7. Department of Psychiatry, Helsinki University Hospital, and University of Helsinki, 00014, Helsinki, Finland. 8. Department of Health, National Institute for Health and Welfare, FI-00014, Helsinki, Finland; and. 9. Endocrinology, Abdominal Center, Helsinki University Hospital, and University of Helsinki, FI-00029, Helsinki, Finland.
Abstract
Context: The associations of body mass index (BMI) and liver fat (LF) with circulating prandial metabolomic markers are incompletely understood. Objective: We aimed to characterize circulating metabolite excursions during an oral glucose tolerance test (OGTT) and evaluate whether the metabolomic signatures of BMI discordance coassociate with LF content. Design, Setting, and Participants: We measured 80 metabolite parameters by nuclear magnetic resonance, together with glucose and insulin, during a 2-hour OGTT in 64 monozygotic (MZ) and 73 dizygotic (DZ) twin pairs (aged 22.8 to 36.2 years). Metabolite excursions during the OGTT were compared within BMI-discordant (intrapair difference, BMI ≥ 3 kg/m2) cotwins separately within MZ and DZ pairs. Insulin-based indices were calculated from the OGTT. LF was measured by magnetic resonance spectroscopy in 25 BMI-discordant MZ pairs. Metabolite profiles were compared with respect to LF discordance (ΔLF% ≥ 2%). Results: We replicated many previously reported OGTT-induced metabolite excursions in all 274 individuals and report novel lipoprotein excursions. The associations between some metabolite excursions and BMI differed in MZ and DZ twins. In BMI-discordant MZ pairs (mean ΔBMI = 4.9 kg/m2) who were concordant for LF (Δ0.2%), few metabolites differed between the cotwins: very-low-density lipoprotein (VLDL) cholesterol and apolipoprotein B were elevated, and high-density lipoprotein size and concentration were decreased in the cotwins with higher BMI. In contrast, in BMI-discordant MZ pairs (ΔBMI = 6.1 kg/m2) who were discordant for LF (Δ6.8%), cotwins with higher BMI exhibited lower insulin sensitivity and widespread metabolomic differences: elevations in small VLDL and low-density lipoprotein particles, fatty acids (FAs), and isoleucine. Within all 64 MZ twin pairs, lower insulin sensitivity associated with higher levels of VLDLs, triglycerides, FAs, and isoleucine. Conclusions: BMI-discordant MZ twin pairs who also are discordant for LF have more pronounced within-pair differences in metabolomics profiles during an OGTT than BMI-discordant pairs without LF discordance.
Context: The associations of body mass index (BMI) and liver fat (LF) with circulating prandial metabolomic markers are incompletely understood. Objective: We aimed to characterize circulating metabolite excursions during an oral glucose tolerance test (OGTT) and evaluate whether the metabolomic signatures of BMI discordance coassociate with LF content. Design, Setting, and Participants: We measured 80 metabolite parameters by nuclear magnetic resonance, together with glucose and insulin, during a 2-hour OGTT in 64 monozygotic (MZ) and 73 dizygotic (DZ) twin pairs (aged 22.8 to 36.2 years). Metabolite excursions during the OGTT were compared within BMI-discordant (intrapair difference, BMI ≥ 3 kg/m2) cotwins separately within MZ and DZ pairs. Insulin-based indices were calculated from the OGTT. LF was measured by magnetic resonance spectroscopy in 25 BMI-discordant MZ pairs. Metabolite profiles were compared with respect to LF discordance (ΔLF% ≥ 2%). Results: We replicated many previously reported OGTT-induced metabolite excursions in all 274 individuals and report novel lipoprotein excursions. The associations between some metabolite excursions and BMI differed in MZ and DZ twins. In BMI-discordant MZ pairs (mean ΔBMI = 4.9 kg/m2) who were concordant for LF (Δ0.2%), few metabolites differed between the cotwins: very-low-density lipoprotein (VLDL) cholesterol and apolipoprotein B were elevated, and high-density lipoprotein size and concentration were decreased in the cotwins with higher BMI. In contrast, in BMI-discordant MZ pairs (ΔBMI = 6.1 kg/m2) who were discordant for LF (Δ6.8%), cotwins with higher BMI exhibited lower insulin sensitivity and widespread metabolomic differences: elevations in small VLDL and low-density lipoprotein particles, fatty acids (FAs), and isoleucine. Within all 64 MZ twin pairs, lower insulin sensitivity associated with higher levels of VLDLs, triglycerides, FAs, and isoleucine. Conclusions: BMI-discordant MZ twin pairs who also are discordant for LF have more pronounced within-pair differences in metabolomics profiles during an OGTT than BMI-discordant pairs without LF discordance.
Authors: Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein Journal: Proc Natl Acad Sci U S A Date: 2009-08-24 Impact factor: 11.205
Authors: J Naukkarinen; S Heinonen; A Hakkarainen; J Lundbom; K Vuolteenaho; L Saarinen; S Hautaniemi; A Rodriguez; G Frühbeck; P Pajunen; T Hyötyläinen; M Orešič; E Moilanen; A Suomalainen; N Lundbom; J Kaprio; A Rissanen; K H Pietiläinen Journal: Diabetologia Date: 2013-10-08 Impact factor: 10.122
Authors: S M Kaye; M Maranghi; L H Bogl; J Kaprio; A Hakkarainen; J Lundbom; N Lundbom; A Rissanen; M R Taskinen; K H Pietiläinen Journal: Obesity (Silver Spring) Date: 2013-05-21 Impact factor: 5.002
Authors: Suzan Wopereis; Carina M Rubingh; Marjan J van Erk; Elwin R Verheij; Trinette van Vliet; Nicole H P Cnubben; Age K Smilde; Jan van der Greef; Ben van Ommen; Henk F J Hendriks Journal: PLoS One Date: 2009-02-26 Impact factor: 3.240
Authors: Jennifer E Ho; Martin G Larson; Ramachandran S Vasan; Anahita Ghorbani; Susan Cheng; Eugene P Rhee; Jose C Florez; Clary B Clish; Robert E Gerszten; Thomas J Wang Journal: Diabetes Date: 2013-02-04 Impact factor: 9.461
Authors: Yuvaraj Mahendran; Henna Cederberg; Jagadish Vangipurapu; Antti J Kangas; Pasi Soininen; Johanna Kuusisto; Matti Uusitupa; Mika Ala-Korpela; Markku Laakso Journal: Diabetes Care Date: 2013-09-11 Impact factor: 19.112
Authors: Peter Würtz; Qin Wang; Antti J Kangas; Rebecca C Richmond; Joni Skarp; Mika Tiainen; Tuulia Tynkkynen; Pasi Soininen; Aki S Havulinna; Marika Kaakinen; Jorma S Viikari; Markku J Savolainen; Mika Kähönen; Terho Lehtimäki; Satu Männistö; Stefan Blankenberg; Tanja Zeller; Jaana Laitinen; Anneli Pouta; Pekka Mäntyselkä; Mauno Vanhala; Paul Elliott; Kirsi H Pietiläinen; Samuli Ripatti; Veikko Salomaa; Olli T Raitakari; Marjo-Riitta Järvelin; George Davey Smith; Mika Ala-Korpela Journal: PLoS Med Date: 2014-12-09 Impact factor: 11.069
Authors: Patrick Weinisch; Jarlei Fiamoncini; Daniela Schranner; Johannes Raffler; Thomas Skurk; Manuela J Rist; Werner Römisch-Margl; Cornelia Prehn; Jerzy Adamski; Hans Hauner; Hannelore Daniel; Karsten Suhre; Gabi Kastenmüller Journal: Front Nutr Date: 2022-09-22